Clinical Trial Update: Adherence to Topical Hydrocortisone 17-butyrate 0.1% (Locoid®) Using Different Vehicles in Adults With Atopic Dermatitis [Phase 4]

View source ↗

Summary

Phase 4 trial updating adherence to topical hydrocortisone 17-butyrate 0.1% (Locoid) with different vehicles in adults with atopic dermatitis; results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Locoid (hydrocortisone 17-butyrate 0.1%)

Snippet

Sponsor: Wake Forest University | Conditions: Atopic Dermatitis | Phase 4 | Status: COMPLETED | Results posted: 2017-03-17